Doseology Sciences Inc. (CSE:MOOD)
0.680
-0.070 (-9.33%)
Dec 4, 2025, 5:29 PM EST
Doseology Sciences Company Description
Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of functional mushroom products with a focus on mental health research in Canada.
The company also offers medicinal mushroom products, including tinctures. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distributors.
The company was formerly known as Pcybin Therapeutic Inc. and changed its name to Doseology Sciences Inc. in January 2020.
Doseology Sciences Inc. was incorporated in 2019 and is based in Kelowna, Canada.
Doseology Sciences Inc.
| Country | Canada |
| Founded | 2019 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Christopher Jackson |
Contact Details
Address: 9-3151 Lakeshore Road Kelowna, British Columbia V1W 3S9 Canada | |
| Phone | 604-908-3095 |
| Website | doseology.com |
Stock Details
| Ticker Symbol | MOOD |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | December - November |
| Reporting Currency | CAD |
| ISIN Number | CA2584842033 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Christopher Jackson | Chief Executive Officer and Director |
| Daniel Vice | Co-Founder and Independent Director |
| Christopher P. Cherry | Chief Financial Officer |
| Timothy Corkum | President and Chief Operating Officer |
| Lindsay Hamelin | Corporate Secretary |